Soesanto Tjokrosonto Soesanto Tjokrosonto
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Correlation of amodiaquine sensitivity to chioroquine and quinine against plasmodium falciparum In Vitro Soesanto Tjokrosonto, Soesanto Tjokrosonto
Journal of the Medical Sciences (Berkala Ilmu Kedokteran) Vol 30, No 03 (1998)
Publisher : Journal of the Medical Sciences (Berkala Ilmu Kedokteran)

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (91.862 KB)

Abstract

Amodiaquine, a 4-aminoquinoline derivative has been introduced since decades ago, and yet the. use remains debatable for its side effects. Chioroquine, the least side effect of antimalarials possessing similarity in pharmacokinetic properties has been less attractive due to the development of resistance worldwide. The return to amodiaquine is debatable. Comparison of the level of sensitivity of 42 isolates to amodiaquine and chloroquine using in-vitro microtesting has been carried out. Amodiaquine was shown to be more sensitive to the isolates as compared to chloroquine. The reasonably high correlation with chloroquine (r=0.62; p<0.05) has referred the alternative treatment of chloroquine resistant falciparum to amodiaquine despite of side effects. The study concluded that amodiaquine remains an alternative drug to chioroquine resistant falciparum malaria in vitro.Key words: falciparum malaria - amodiaquine - chioroquine - quinine - in vitro
Correlation of amodiaquine sensitivity to chioroquine and quinine against plasmodium falciparum In Vitro Soesanto Tjokrosonto Soesanto Tjokrosonto
Journal of the Medical Sciences (Berkala Ilmu Kedokteran) Vol 30, No 03 (1998)
Publisher : Journal of the Medical Sciences (Berkala Ilmu Kedokteran)

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (91.862 KB)

Abstract

Amodiaquine, a 4-aminoquinoline derivative has been introduced since decades ago, and yet the. use remains debatable for its side effects. Chioroquine, the least side effect of antimalarials possessing similarity in pharmacokinetic properties has been less attractive due to the development of resistance worldwide. The return to amodiaquine is debatable. Comparison of the level of sensitivity of 42 isolates to amodiaquine and chloroquine using in-vitro microtesting has been carried out. Amodiaquine was shown to be more sensitive to the isolates as compared to chloroquine. The reasonably high correlation with chloroquine (r=0.62; p<0.05) has referred the alternative treatment of chloroquine resistant falciparum to amodiaquine despite of side effects. The study concluded that amodiaquine remains an alternative drug to chioroquine resistant falciparum malaria in vitro.Key words: falciparum malaria - amodiaquine - chioroquine - quinine - in vitro